AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis

Authors: Kathline Kim, Dan H. Moore, Alexandros Makriyannis, Mary E. Abood - European Journal of Pharmacology 2006 cited by 149